What is he best known for?
The fields of study he is best known for:
- Virus
- Antibody
- Immune system
David C. Montefiori focuses on Virology, Antibody, Immunology, Virus and Neutralizing antibody.
His studies in Virology integrate themes in fields like Epitope and Immune system.
His Antibody study combines topics from a wide range of disciplines, such as Molecular biology and Antigen.
As part of the same scientific family, David C. Montefiori usually focuses on Immunology, concentrating on AIDS Vaccines and intersecting with HIV vaccine.
His Virus research includes themes of Vaccinia, Recombinant DNA, Immunization and Glycoprotein.
His biological study spans a wide range of topics, including Viral envelope, Affinity maturation, Luciferase, Humoral immunity and Immunogen.
His most cited work include:
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes (2069 citations)
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (1582 citations)
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (1399 citations)
What are the main themes of his work throughout his whole career to date?
David C. Montefiori spends much of his time researching Virology, Antibody, Immunology, Virus and Immune system.
His Virology study frequently links to related topics such as Epitope.
The study incorporates disciplines such as Molecular biology, Glycoprotein, Glycan and Binding site in addition to Epitope.
His work in Antibody addresses subjects such as Antigen, which are connected to disciplines such as Adjuvant.
His study focuses on the intersection of Immunology and fields such as HIV vaccine with connections in the field of Antibody-dependent cell-mediated cytotoxicity.
His Virus research includes elements of Vaccinia, Recombinant DNA and Heterologous.
He most often published in these fields:
- Virology (86.28%)
- Antibody (58.84%)
- Immunology (45.66%)
What were the highlights of his more recent work (between 2016-2021)?
- Antibody (58.84%)
- Virology (86.28%)
- Neutralization (21.76%)
In recent papers he was focusing on the following fields of study:
David C. Montefiori mainly investigates Antibody, Virology, Neutralization, Virus and Immunology.
His Antibody study incorporates themes from HIV vaccine, Immune system and Vaccination.
His Immune system study integrates concerns from other disciplines, such as Avidity, Antibody-dependent cell-mediated cytotoxicity and B cell.
His specific area of interest is Virology, where he studies Neutralizing antibody.
Heptad repeat is closely connected to Gp41 in his research, which is encompassed under the umbrella topic of Neutralization.
His research in Virus intersects with topics in Transmission and Heterologous.
Between 2016 and 2021, his most popular works were:
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. (1255 citations)
- Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 (304 citations)
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. (174 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Antibody, Virology, Virus, Neutralization and Neutralizing antibody.
The subject of his Antibody research is within the realm of Immunology.
David C. Montefiori has researched Immunology in several fields, including Transmission and AIDSVAX.
His Virology research includes themes of Immunization, Glycoprotein, Glycan, Epitope and Immunogen.
David C. Montefiori works mostly in the field of Virus, limiting it down to topics relating to In vitro and, in certain cases, In vivo.
His Neutralization research integrates issues from Infectivity, Peripheral blood mononuclear cell, Antigen and Severe acute respiratory syndrome coronavirus 2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
